Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04895748
Title DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
City of Hope National Medical Duarte California 91010 United States Details
Massachusetts General Hospital . Boston Massachusetts 02114 United States Details
Washington Uni School of Med Main Center Saint Louis Missouri 63110 United States Details
Memorial Sloane Ketterin Cancer Ctr . New York New York 10065 United States Details
Uni of TX MD Anderson Cancer Cntr Dept.ofMDAndersonCancerCtr(8) Houston Texas 77030 United States Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Koto ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field